TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7719221

Group type: EXPERIMENTAL
Intervention: Oral cancer patients with second cancers
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Patients with second cancers
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Initial localized cancer
Number of subjects: 1090
Study: 2906897

Group type: EXPERIMENTAL
Intervention: 0.5 mg bopindolol
Number of subjects: 115

Group type: COMPARATOR
Intervention: 0 mg (placebo)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: 2.0 mg bopindolol
Number of subjects: 115
Study: 29338142

Group type: EXPERIMENTAL
Intervention: Background infusion of 5 mL/h plus 5 mL demand bolus doses with 10-minute lockout (group B/D)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Only demand bolus doses of 5 mL with 10-minute lockout (group D)
Number of subjects: 52
Study: 27235956

Group type: EXPERIMENTAL
Intervention: 15-minute music
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: 30-minute music
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control (no music)
Number of subjects: 133
Study: 24010876

Group type: EXPERIMENTAL
Intervention: CS21 barrier genital gel®
Number of subjects: 61

Group type: COMPARATOR
Intervention: Topical aciclovir
Number of subjects: 61

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 61
Study: 23563040

Group type: EXPERIMENTAL
Intervention: Metformin (3 g daily)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 20568429

Group type: EXPERIMENTAL
Intervention: Scalp penetration acupuncture through Baihui (GV 20) to Taiyang (EX‐HN 5) on the affected side, with four needles relay.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional scalp acupuncture at anterior oblique line of parietotemporal region, with four needles relay.
Number of subjects: 60
Study: 18266835

Group type: EXPERIMENTAL
Intervention: Intervention group (specific intervention details not available)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dog ownership (year 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Respiratory syncytial viral infection (detected at 12 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal smoking (year 7)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dog ownership (year 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indoor environmental exposures (year 7)
Number of subjects: 0
Study: 16390901

Group type: EXPERIMENTAL
Intervention: Somatic/affective symptoms
Number of subjects: 2466

Group type: EXPERIMENTAL
Intervention: Cognitive/affective symptoms
Number of subjects: 2466

Group type: EXPERIMENTAL
Intervention: Appetitive symptoms
Number of subjects: 2466
Study: 12595785

Group type: EXPERIMENTAL
Intervention: CBT plus imipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: CBT plus placebo
Number of subjects: 0
Study: 10916893

Group type: EXPERIMENTAL
Intervention: Intervention group (IG): Group health education session and postal back-up every three months for two years
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (CG): Health education from their doctor
Number of subjects: 110
Study: 8752182

Group type: EXPERIMENTAL
Intervention: QRS(+) pattern (n = 85)
Number of subjects: 378

Group type: COMPARATOR
Intervention: QRS(−) pattern (n = 293)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Anterior AMI with QRS(+)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Non-anterior AMI
Number of subjects: 378
Study: 1569622

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) 30/ng/kg/min IV for up to 7 days
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo IV for up to 7 days
Number of subjects: 146
Study: 2868899

Group type: EXPERIMENTAL
Intervention: Ro 31-1118 (10 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ro 31-1118 (20 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ro 31-1118 (40 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ro 31-1118 (80 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ro 31-1118 (all doses)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31378648

Group type: EXPERIMENTAL
Intervention: Congruent storybook (celeriac)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Congruent sensory play (celeriac)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Incongruent sensory play (carrot)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Storybook only conditions
Number of subjects: 337
Study: 29514697

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GDFT
Number of subjects: 0
Study: 26901343

Group type: EXPERIMENTAL
Intervention: THC:CBD oromucosal spray
Number of subjects: 300
Study: 24331983

Group type: EXPERIMENTAL
Intervention: 1000 mg acetaminophen/10 mg hydrocodone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 21616626

Group type: EXPERIMENTAL
Intervention: Web-based Diabetes Interactive Education Programme (DIEP)
Number of subjects: 99
Study: 20642326

Group type: EXPERIMENTAL
Intervention: 0.5-g progesterone vaginal rings (PVR)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 1-g progesterone vaginal rings (PVR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Transdermal estradiol (50 microg/day)
Number of subjects: 44
Study: 17569202

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) screening for lung cancer
Number of subjects: 0
Study: 14998844

Group type: EXPERIMENTAL
Intervention: Carboplatin 840 mg/m2 administered continuously during 6 weeks of radiotherapy (60 Gy)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Thoracic radiotherapy alone (60 Gy)
Number of subjects: 160
Study: 12421891

Group type: EXPERIMENTAL
Intervention: Intranasal application of lysine aspirin for two weeks (5 patients)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo for two weeks (4 patients)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Intranasal application of lysine aspirin for six months (5 patients)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo for six months (4 patients)
Number of subjects: 34
Study: 9843456

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 586

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 586
Study: 7863253

Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg/day for one year (Group A)
Number of subjects: 581

Group type: COMPARATOR
Intervention: Intermittent treatment with nizatidine (Group B)
Number of subjects: 581
Study: 2783580

Group type: EXPERIMENTAL
Intervention: Supportive-educative telephone program implemented by a cardiac rehabilitation nurse specialist
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study: 31724170

Group type: EXPERIMENTAL
Intervention: Dose-dense chemotherapy (administered every 2 weeks)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Dose-dense chemotherapy with trastuzumab
Number of subjects: 452

Group type: COMPARATOR
Intervention: Standard-interval chemotherapy (administered every 3 weeks)
Number of subjects: 452
Study: 29998997

Group type: EXPERIMENTAL
Intervention: Yangyin Tiluo Decoction (YTD) for 4 weeks (200 mL of the decoction two times daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy control (no intervention)
Number of subjects: 12
Study: 28254383

Group type: EXPERIMENTAL
Intervention: Self-expanding paclitaxel-eluting stent (PES) with a nominal diameter of 6mm
Number of subjects: 20

Group type: COMPARATOR
Intervention: Self-expanding paclitaxel-eluting stent (PES) with a nominal diameter of 8mm
Number of subjects: 20
Study: 26227019

Group type: EXPERIMENTAL
Intervention: 3-h serum sample
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 3-h serum measurement with GFR
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 3-h serum isotope levels in Cohort 2
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 5-h serum isotope levels in Cohort 2
Number of subjects: 29
Study: 24257388

Group type: EXPERIMENTAL
Intervention: Oral midazolam
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Video glasses
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combined (midazolam + video glasses)
Number of subjects: 96
Study: 20843496

Group type: EXPERIMENTAL
Intervention: Mail reminder group (letter plus CDC Influenza Vaccine Information Statement)
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Phone reminder group (personal phone call with same information)
Number of subjects: 884

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 884
Study: 18396369

Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 16330297

Group type: EXPERIMENTAL
Intervention: Olanzapine (10 mg IM single injection)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Haloperidol (7.5 mg IM single injection)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Haloperidol (7.5 mg IM multiple injections)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Olanzapine (10 mg IM multiple injections)
Number of subjects: 236
Study: 12534508

Group type: COMPARATOR
Intervention: 585-nm pulsed dye laser (PDL) alone
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 585-nm pulsed dye laser (PDL) with intralesional corticosteroids
Number of subjects: 22
Study: 11140808

Group type: EXPERIMENTAL
Intervention: l-carnitine (20 mg/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 16
Study: 8879897

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan (6 mg)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 1773997

Group type: EXPERIMENTAL
Intervention: Early mobilization in a stabilizing orthosis
Number of subjects: 80

Group type: COMPARATOR
Intervention: Total immobilization in a walking plaster cast
Number of subjects: 80
Study: 6408672

Group type: EXPERIMENTAL
Intervention: Alcohol (1.0 g/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30526051

Group type: EXPERIMENTAL
Intervention: Brinzolamide-brimonidine fixed combination
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 62
Study: 30706521

Group type: EXPERIMENTAL
Intervention: Fluid distribution timetable
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 24
Study: 26745962

Group type: EXPERIMENTAL
Intervention: Long-duration tourniquet use
Number of subjects: 50

Group type: COMPARATOR
Intervention: Short-duration tourniquet use
Number of subjects: 50
Study: 26588807

Group type: EXPERIMENTAL
Intervention: Exercise test using dry air
Number of subjects: 146
Study: 25764777

Group type: EXPERIMENTAL
Intervention: Standard therapy (neurodevelopmental rehabilitation and classic kinesiotherapy) plus botulinum toxin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy (neurodevelopmental rehabilitation and classic kinesiotherapy)
Number of subjects: 0
Study: 22631564

Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 301
Study: 19651803

Group type: EXPERIMENTAL
Intervention: Glabridin (licorice-root ethanol extract)
Number of subjects: 0
Study: 16836903

Group type: EXPERIMENTAL
Intervention: Detection of putative periodontal microorganisms in AgP patients using 16S rRNA based PCR
Number of subjects: 72

Group type: COMPARATOR
Intervention: Detection of putative periodontal microorganisms in healthy controls using 16S rRNA based PCR
Number of subjects: 72
Study: 12791117

Group type: EXPERIMENTAL
Intervention: Bolus dose alone (BD) - pethidine 0.3 mg.kg‐1 loading dose and 150 micro g.kg‐1 bolus intravenously
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bolus dose with background infusion (BD + BI) - pethidine 0.3 mg.kg‐1 loading dose, 75 micro g.kg‐1 bolus, and 15 micro g.kg‐1.h‐1 background infusion
Number of subjects: 40
Study: 11004355

Group type: EXPERIMENTAL
Intervention: Cervical membrane sweeping during induction of labor
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Cervical membrane sweeping during induction of labor with oxytocin alone
Number of subjects: 130
Study: 8968267

Group type: EXPERIMENTAL
Intervention: Diaspirin cross‐linked hemoglobin solution (100 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diaspirin cross‐linked hemoglobin solution (25 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diaspirin cross‐linked hemoglobin solution (50 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diaspirin cross‐linked hemoglobin solution
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (lactated Ringer's solution)
Number of subjects: 24
Study: 1298079

Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg twice daily for two weeks
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 6734299

Group type: EXPERIMENTAL
Intervention: Lorcainide
Number of subjects: 13

Group type: COMPARATOR
Intervention: Quinidine
Number of subjects: 13
Study: 31216604

Group type: EXPERIMENTAL
Intervention: Tangible support
Number of subjects: 151
Study: 29590719

Group type: EXPERIMENTAL
Intervention: Smelling amniotic fluid for 15 minutes before, during, and after peripheral cannulation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 61
Study: 26560899

Group type: EXPERIMENTAL
Intervention: PEH-MR 30-mg modified-release tablets every 12 hours for 7 days
Number of subjects: 575

Group type: COMPARATOR
Intervention: Placebo every 12 hours for 7 days
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: PEH-MR 30-mg modified-release tablets
Number of subjects: 575

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: PEH-MR and placebo
Number of subjects: 575
Study: 23864363

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) plus standard care
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 26
Study: 22050410

Group type: EXPERIMENTAL
Intervention: Buspirone 20-mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18562023

Group type: EXPERIMENTAL
Intervention: Coronary spasm group (ACh testing)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Coronary spasm group (sublingual nitroglycerin)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (sublingual nitroglycerin)
Number of subjects: 33
Study: 17804953

Group type: EXPERIMENTAL
Intervention: Clinical Dementia Rating (CDR)
Number of subjects: 343
Study: 16175767

Group type: EXPERIMENTAL
Intervention: Radial shock wave therapy (RSWT) - 2000 impulses, 4 weeks treatment
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group - 20 impulses of RSWT, 4 weeks treatment
Number of subjects: 62
Study: 12391035

Group type: EXPERIMENTAL
Intervention: Running
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cycling
Number of subjects: 10
Study: 10713581

Group type: EXPERIMENTAL
Intervention: 10‐item Abbreviated Mental Test (AMT)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: 18‐item Chinese Mini‐Mental Status Examination (CMMSE)
Number of subjects: 246

Group type: COMPARATOR
Intervention: AMT and CMMSE
Number of subjects: 246
Study: 8691224

Group type: EXPERIMENTAL
Intervention: Coronary artery revascularization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study: 1736698

Group type: EXPERIMENTAL
Intervention: Epidural butorphanol 2 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intravenous butorphanol 2 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 45
Study: 6386593

Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg intravenous infusion
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 31262348

Group type: EXPERIMENTAL
Intervention: Fimasartan
Number of subjects: 119

Group type: COMPARATOR
Intervention: Perindopril
Number of subjects: 119
Study: 29966801

Group type: EXPERIMENTAL
Intervention: Structured nurse-coordinated intensive intervention program (9 one-to-one sessions over a mean period of 5 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured nurse-coordinated intensive intervention program
Number of subjects: 0
Study: 27378545

Group type: EXPERIMENTAL
Intervention: Parent present during dental treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Parent absent during dental treatment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Children's perception of their treatment
Number of subjects: 100
Study: 25192777

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Continuous Moderate-Intensity Training (CMT)
Number of subjects: 14
Study: 22402934

Group type: EXPERIMENTAL
Intervention: Supervised exercise training (SET) for PAD patients, duration of 3 weeks and 12 weeks, specific details on dosage not applicable.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (30 control subjects), no intervention reported.
Number of subjects: 22
Study: 19201066

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over left primary motor cortex (M1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 17388747

Group type: EXPERIMENTAL
Intervention: Formoterol turbuhaler (FT) 9 mug
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Salbutamol diskus (SD) 200 mug
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 16139699

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 15 s after 60 s etching of enamel and 20 s etching of dentin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 15 s
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 30 s
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 45 s
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system Adper Prompt L-Pop applied for 15, 30, and 45 s without pre-etching
Number of subjects: 40
Study: 12494049

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg t.i.d.)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg o.d.)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no calcium antagonists)
Number of subjects: 88
Study: 10529464

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7777113

Group type: EXPERIMENTAL
Intervention: Serum transaminases (ST) levels in hemodialysis patients
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic (ROC) analysis for ST
Number of subjects: 217

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 217
Study: 2323650

Group type: EXPERIMENTAL
Intervention: Induction and consolidation chemotherapy with weekly parenteral vincristine, Adriamycin, l-asparaginase and daily oral prednisone (VAAP), followed by standard CNS prophylaxis. Maintenance therapy for 3 years with daily 6-mercaptopurine, weekly methotrexate and monthly intrathecal therapy, with drug intensification comprising either vincristine, Adriamycin and l-asparaginase (VAA) or cyclophosphamide, vincristine, cytosine arabinoside and prednisone (COAP).
Number of subjects: 85
Study: 389512

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Procaineamide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 10
Study: 31814419

Group type: EXPERIMENTAL
Intervention: Music training (improvisation exercises)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no music training)
Number of subjects: 45
Study: 31892758

Group type: EXPERIMENTAL
Intervention: AHP disinfectant wipes
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alcohol disinfectant wipes
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: QAC disinfectant wipes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Untreated (NT) keyboards
Number of subjects: 30
Study: 28709776

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 241

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 241

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 241

Group type: COMPARATOR
Intervention: Aripiprazole
Number of subjects: 241
Study: 27217453

Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone agonist (GnRHa) plus norethisterone
Number of subjects: 129

Group type: COMPARATOR
Intervention: Norethisterone alone (control group)
Number of subjects: 129
Study: 26711437

Group type: EXPERIMENTAL
Intervention: 10 ml single use dropper bottle
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: 3 g single application squeeze tube containing gel
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: 100 ml bottle with cotton swab
Number of subjects: 204
Study: 23244045

Group type: EXPERIMENTAL
Intervention: Retro-cued items
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uncued objects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Color retro-cues
Number of subjects: 0
Study: 19408119

Group type: EXPERIMENTAL
Intervention: Remote Simultaneous Medical Interpreting (RSMI)
Number of subjects: 782

Group type: COMPARATOR
Intervention: Usual and Customary (U&C) interpreting
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: BDI-FS positive patients (overall)
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: Chinese speakers among BDI-FS positive patients
Number of subjects: 782
Study: 19040739

Group type: EXPERIMENTAL
Intervention: Ilioinguinal-iliohypogastric nerve block (IINB) with 0.5% bupivacaine + 5 mcg/ml epinephrine (Group I, n = 28)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline control (Group II, n = 32)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ilioinguinal-iliohypogastric nerve block (IINB) (Group I)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline control (Group II)
Number of subjects: 60
Study: 16172569

Group type: EXPERIMENTAL
Intervention: 99mTc‐EDDA‐hydrazinonicotinyl‐Tyr3‐octreotide (Tc‐TOC)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: SPECT imaging
Number of subjects: 88